
Sign up to save your podcasts
Or


Please listen in as Drs. Piltin, van Akkooi, and Hyngstrom discuss relevant clinical trial presentations from ASCO 2024 annual meeting and their impressions on the implications for surgical oncologists. Abstracts results discussed include the neoadjuvant NADINA and PIVOTAL trials as well as an initial report on upfront TIL therapy for stage IV patients.
By Society of Surgical Oncology5
1212 ratings
Please listen in as Drs. Piltin, van Akkooi, and Hyngstrom discuss relevant clinical trial presentations from ASCO 2024 annual meeting and their impressions on the implications for surgical oncologists. Abstracts results discussed include the neoadjuvant NADINA and PIVOTAL trials as well as an initial report on upfront TIL therapy for stage IV patients.

43,549 Listeners

15,710 Listeners

4,335 Listeners

319 Listeners

496 Listeners

1,306 Listeners

2,440 Listeners

112,065 Listeners

56,481 Listeners

8,484 Listeners

7 Listeners

225 Listeners

278 Listeners

15,853 Listeners

192 Listeners